Skip to Main Content

Author Details

Roger A Barker
John Van Geest Center for Brain Repair, University of Cambridge
1986
527
95
PMIDPaper TitleJournal TitlePublished Year
37979092Plasma GFAP and its association with disease severity in Huntington's disease.J Neurol2024
36343661Mitochondrial haplogroups and cognitive progression in Parkinson's disease.Brain2023
37669861Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy.J Neurosci2023
37910626LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification.Sci Adv2023
37802036Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD.Cell Stem Cell2023
37788254Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.PLoS One2023
37986877A spatial human thymus cell atlas mapped to a continuous tissue axis.bioRxiv2023
37824650Comprehensive cell atlas of the first-trimester developing human brain.Science2023
37291143A multicentre study on grey matter morphometric biomarkers for classifying early schizophrenia and parkinson's disease psychosis.NPJ Parkinsons Dis2023
37248911Sleep Dysfunction in Huntington's Disease: Impacts of Current Medications and Prospects for Treatment.J Huntingtons Dis2023
36993946B lymphocyte responses in Parkinson's disease and their possible significance in disease progression.Brain Commun2023
36651994Detection of antibodies against the huntingtin protein in human plasma.Cell Mol Life Sci2023
36824730Generation of human cerebral organoids with a structured outer subventricular zone.bioRxiv2023
36563687Lessons learnt, and still to learn, in first in human stem cell trials.Stem Cell Reports2023
36321260Selective neurodegeneration generated by intravenous α-synuclein pre-formed fibril administration is not associated with endogenous α-synuclein levels in the rat brain.Brain Pathol2023
34413240Huntington's disease: diagnosis and management.Pract Neurol2022
35732412Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts.J Neurol Neurosurg Psychiatry2022
35577512Combining biomarkers for prognostic modelling of Parkinson's disease.J Neurol Neurosurg Psychiatry2022
35576973Locus Coeruleus Integrity from 7â¿¿T MRI Relates to Apathy and Cognition in Parkinsonian Disorders.Mov Disord2022
35468035Hunting out the autophagic problem in Huntington disease.Autophagy2022
35463389Metacognitive insight into cognitive performance in Huntington's disease gene carriers.BMJ Neurol Open2022
35533200Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes.PLoS Comput Biol2022
36150382Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease.Stem Cell Reports2022
36174572Myeloid cell interferon secretion restricts Zika flavivirus infection of developing and malignant human neural progenitor cells.Neuron2022
36361956Brain Regional Identity and Cell Type Specificity Landscape of Human Cortical Organoid Models.Int J Mol Sci2022
36305490Single-cell transcriptional and functional analysis of dopaminergic neurons in organoid-like cultures derived from human fetal midbrain.Development2022
34936701Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease.Brain2022
35165768Exploring the predictors of financial impairment in Huntington's disease using the Enroll-HD dataset.J Neurol2022
34637857Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissue.Neurosci Lett2022
33002231Differences in the Presentation and Progression of Parkinson's Disease by Sex.Mov Disord2021
33547074Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell.Sci Adv2021
33783470Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.Brain2021
34943958Reprogramming Human Adult Fibroblasts into GABAergic Interneurons.Cells2021
34526889The Cerebrospinal Fluid Profile of Cholesterol Metabolites in Parkinson's Disease and Their Association With Disease State and Clinical Features.Front Aging Neurosci2021
34497389Cells of the human intestinal tract mapped across space and time.Nature2021
33963552Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.Mov Disord2021
34039994Early constipation predicts faster dementia onset in Parkinson's disease.NPJ Parkinsons Dis2021
33958783Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson's disease.Nat Genet2021
33958447The coding and long noncoding single-cell atlas of the developing human fetal striatum.Science2021
34202701Problems with Social Cognition and Decision-Making in Huntington's Disease: Why Is it Important?Brain Sci2021
34032267MEIS-WNT5A axis regulates development of fourth ventricle choroid plexus.Development2021
34334425Stem Cell-Derived Dopamine Neurons: Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?J Parkinsons Dis2021
33975081Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients.Parkinsonism Relat Disord2021
341659043D-Printed Soft Lithography for Complex Compartmentalized Microfluidic Neural Devices.Adv Sci (Weinh)2021
34024781Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort.J Parkinsons Dis2021
34048692ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.Stem Cell Reports2021
34162837Single cell derived mRNA signals across human kidney tumors.Nat Commun2021
31758091Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease.Mol Psychiatry2021
33340059Correction to: The Treatment of Sleep Dysfunction in Neurodegenerative Disorders.Neurotherapeutics2021
33111402Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.Mov Disord2021
  • 1 - 50 of 527

Recommended Authors

Jeha Jeon
Department of Psychiatry and McLean Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 2
Mathieu Bourdenx
University College London, UK Dementia Research Institute
Career Start Year 2013
Number of shared co-authors 1
Roger A Barker
University of Cambridge
Career Start Year 2013
Number of shared co-authors 14
Jessika Suescun
McGovern Medical School, University of Texas Health Science Center at Houston
Career Start Year 2013
Number of shared co-authors 0
Claire Henchcliffe
Weill Cornell Medicine/New York Presbyterian Hospital
Career Start Year 2006
Number of shared co-authors 1
Kelly E Glajch
Neurodegenerative Diseases Research Unit
Career Start Year 2006
Number of shared co-authors 0
Jun Peng
College of Animal Science and Technology, Huazhong Agricultural University
Career Start Year 2002
Number of shared co-authors 1
Celine Perier
Vall d'Hebron Research Institute (VHIR)
Career Start Year 2000
Number of shared co-authors 3
Anders Johansson
Dept of Clinical Neurosciences, Karolinska Institutet
Career Start Year 2000
Number of shared co-authors 1
Hubert H Fernandez
Center for Neurological Restoration, Neurological Institute, Cleveland Clinic
Career Start Year 1998
Number of shared co-authors 7
Karen E Anderson
Georgetown University
Career Start Year 1996
Number of shared co-authors 5
Giselle M Petzinger
Keck School of Medicine, University of Southern California
Career Start Year 1995
Number of shared co-authors 2
Samuel M Goldman
University of California-San Francisco
Career Start Year 1994
Number of shared co-authors 5
Zoltan Mari
Lou Ruvo Center for Brain Health, Cleveland Clinic Nevada
Career Start Year 1991
Number of shared co-authors 3
Nil Dizdar
Department of Biomedical and Clinical Sciences, Linkoping University
Career Start Year 1991
Number of shared co-authors 3
Michael G Kaplitt
Weill Cornell Medical College
Career Start Year 1991
Number of shared co-authors 1
Steven Finkbeiner
J. David Gladstone Institutes
Career Start Year 1988
Number of shared co-authors 13
Valina L Dawson
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Career Start Year 1988
Number of shared co-authors 7
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 0
Bj??rn Holmberg
Sahlgrenska University Hospital
Career Start Year 1988
Number of shared co-authors 2
Eliezer Masliah
National Institute On Aging
Career Start Year 1986
Number of shared co-authors 20
Michael W Jakowec
Keck School of Medicine, University of Southern California
Career Start Year 1985
Number of shared co-authors 0
Ronald J Mandel
University of Florida College of Medicine
Career Start Year 1985
Number of shared co-authors 3
Sven P??lhagen
Department of Neurology Karolinska University Hospital Huddinge Stockholm Sweden.
Career Start Year 1984
Number of shared co-authors 1
Mya C Schiess
McGovern Medical School at UTHealth
Career Start Year 1982
Number of shared co-authors 0
Steven M Hersch
Inc. University Avenue
Career Start Year 1980
Number of shared co-authors 5
Thomas L Davis
Vanderbilt University Medical Center
Career Start Year 1979
Number of shared co-authors 1
Jan Linder
Division of Clinical Neuroscience, Umea University
Career Start Year 1976
Number of shared co-authors 2
Lawrence S Honig
University of California
Career Start Year 1975
Number of shared co-authors 13
John Q Trojanowski
University of Pennsylvania
Career Start Year 1974
Number of shared co-authors 23

Collaborators

David J Burn
Population Health Sciences Institute, Newcastle University
Co-authored papers 50
Nicholas W Wood
UCL Queen Square Institute of Neurology
Co-authored papers 21
Huw R Morris
Queen Square Institute of Neurology, University College London
Co-authored papers 20
Stephen Sawcer
Co-authored papers 16
Yoav Ben-Shlomo
Co-authored papers 16
An Goris
Co-authored papers 9
Patrick F Chinnery
School of Clinical Medicine, University of Cambridge
Co-authored papers 9
Peter Heutink
German Center for Neurodegenerative Diseases (DZNE).
Co-authored papers 8
Alexis Brice
Sorbonne University, Paris Brain Institute - ICM, Inserm, CNRS
Co-authored papers 8
Andrew B Singleton
National Institute on Aging
Co-authored papers 7
Nick C Fox
UK Dementia Research Institute, University College London
Co-authored papers 7
H??kan Widner
Skane University Hospital
Co-authored papers 6
Omer Ali Bayraktar
Wellcome Sanger Institute
Co-authored papers 6
Mike A Nalls
Center for Alzheimer's and Related Dementias, National Institutes of Health
Co-authored papers 6
Jeremy Sugarman
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 5
Sarah A Teichmann
Wellcome Sanger Institute
Co-authored papers 5
Muzlifah Haniffa
Wellcome Sanger Institute
Co-authored papers 5
Lorenz Studer
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Maria Ban
Co-authored papers 4
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Co-authored papers 4
Daniel R Weinberger
Co-authored papers 4
Douglas Sipp
RIKEN Center for Biosystems Dynamics Research
Co-authored papers 4
Jonathan Kimmelman
McGill University
Co-authored papers 4
Jun Takahashi
Center for iPS Cell Research and Application, Kyoto University
Co-authored papers 4
Michael A Schwarzschild
Co-authored papers 4
Maria Thom
Hanoi Medical University Hospital
Co-authored papers 3
Heather M Rooke
Broad Institute of Harvard and MIT
Co-authored papers 3
Aaron G Day-Williams
Co-authored papers 3
Melissa K Carpenter
Carpenter Group Consulting Inc., USA NxCell Inc., USA Q Therapeutics Inc.
Co-authored papers 3
R Alta Charo
University of Wisconsin-Madison/Nuclear Threat Initiative
Co-authored papers 3
Release 1.2